LYRA – lyra therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Lyra Therapeutics GAAP EPS of -$1.43 misses by $0.10, revenue of $1.53M [Seeking Alpha]
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Form DEFA14A Lyra Therapeutics, Inc.
Form DEF 14A Lyra Therapeutics, Inc. For: May 14
Form PRE 14A Lyra Therapeutics, Inc. For: May 14
Form S-8 Lyra Therapeutics, Inc.
Form 10-K Lyra Therapeutics, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.